Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1347

1.

Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.

Bonthuis M, Busutti M, van Stralen KJ, Jager KJ, Baiko S, Bakkaloğlu S, Battelino N, Gaydarova M, Gianoglio B, Parvex P, Gomes C, Heaf JG, Podracka L, Kuzmanovska D, Molchanova MS, Pankratenko TE, Papachristou F, Reusz G, Sanahuja MJ, Shroff R, Groothoff JW, Schaefer F, Verrina E.

Clin J Am Soc Nephrol. 2015 May 7;10(5):767-75. doi: 10.2215/CJN.06200614. Epub 2015 Feb 20.

PMID:
25710805
2.

Pathophysiology and treatment of nonfamilial hyperparathyroidism.

Lumachi F, Basso SM.

Recent Pat CNS Drug Discov. 2014;9(3):164-72.

PMID:
25643126
3.

[Clinical characteristics of patients with IgA nephropathy and long-term survival after dialysis therapy].

Komatsu H, Nakagawa H, Iwakiri T, Toida T, Fukuda A, Kikuchi M, Sato Y, Kitamura K, Fujimoto S.

Nihon Jinzo Gakkai Shi. 2014;56(8):1251-9. Japanese.

PMID:
25551986
4.

Sodium zirconium cyclosilicate in hyperkalemia.

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B.

N Engl J Med. 2015 Jan 15;372(3):222-31. doi: 10.1056/NEJMoa1411487. Epub 2014 Nov 21.

PMID:
25415807
5.

Cardiovascular disease and its relationship with chronic kidney disease.

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, Zhang PY.

Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2918-26.

6.

Oral manifestations in a renal osteodystrophy patient - a case report with review of literature.

J P, Nisha V A, Gs A, Ca P, Mm V.

J Clin Diagn Res. 2014 Aug;8(8):ZD28-30. doi: 10.7860/JCDR/2014/8879.4722. Epub 2014 Aug 20.

7.

Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Turenne MN, Cope EL, Porenta S, Mukhopadhyay P, Fuller DS, Pearson JM, Dahlerus C, Lantz B, Tentori F, Robinson BM.

J Am Soc Nephrol. 2015 Mar;26(3):754-64. doi: 10.1681/ASN.2013111232. Epub 2014 Oct 9.

PMID:
25300289
8.

High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI.

J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2.

PMID:
25278510
9.

Ankle-brachial index and bone turnover in patients on dialysis.

London GM, Marchais SJ, Guérin AP, de Vernejoul MC.

J Am Soc Nephrol. 2015 Feb;26(2):476-83. doi: 10.1681/ASN.2014020169. Epub 2014 Sep 17.

PMID:
25231881
10.

[Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease].

Dzgoeva FU, Gatagonova TM, Bestaeva TL, Sopoev MIu, Bazaeva BG, Khamitsaeva OV.

Ter Arkh. 2014;86(6):63-9. Russian.

PMID:
25095658
11.

Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.

Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4315-20. doi: 10.1210/jc.2014-2372. Epub 2014 Aug 5.

PMID:
25093620
12.

Effects of switching from sevelamer hydrochloride to bixalomer on laboratory parameters in hemodialysis patients.

Furukawa K, Ikawa T, Yokoi S, Yokouchi S, Kato K, Ueno M, Takahashi J.

Ther Apher Dial. 2014 Jun;18 Suppl 2:2-7. doi: 10.1111/1744-9987.12227.

PMID:
24975888
13.

The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.

Matsuo A, Iida A, Tanimoto M, Matsushita M, Miyamoto K.

Ren Fail. 2014 Sep;36(8):1291-7. doi: 10.3109/0886022X.2014.930491. Epub 2014 Jun 30.

PMID:
24975675
14.

Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan.

Kishi Y, Obara Y, Hara K, Yamashiro H, Kurosawa N, Takada D.

Ther Apher Dial. 2014 Jun;18 Suppl 1:9-13. doi: 10.1111/1744-9987.12197.

PMID:
24953760
15.

Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients.

Ohya M, Negi S, Sakaguchi T, Koiwa F, Ando R, Komatsu Y, Shinoda T, Inaguma D, Joki N, Yamaka T, Ikeda M, Shigematsu T.

J Clin Endocrinol Metab. 2014 Oct;99(10):3873-8. doi: 10.1210/jc.2013-4396. Epub 2014 Jun 17.

PMID:
24937533
16.

Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).

Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, Alonso A, Chonchol M, Deo R, Ix JH, Siscovick DS, Kestenbaum B, de Boer IH.

Circulation. 2014 Jul 22;130(4):298-307. doi: 10.1161/CIRCULATIONAHA.113.005499. Epub 2014 Jun 11.

PMID:
24920722
17.

Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.

Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, Oliveira EC, Graciolli FG, Passlick-Deetjen J, Jorgetti V, Moysés RM.

BMC Nephrol. 2014 May 3;15:69. doi: 10.1186/1471-2369-15-69.

18.

A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy.

Takashima T, Sanai T, Miyazono M, Fukuda M, Kishi T, Nonaka Y, Yoshizaki M, Sato S, Ikeda Y.

PLoS One. 2014 May 20;9(5):e97859. doi: 10.1371/journal.pone.0097859. eCollection 2014.

19.

A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.

Prajapati VA, Galani VJ, Shah PR.

Saudi J Kidney Dis Transpl. 2014 May;25(3):530-8.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk